Efficacy and safety of bivalirudin in coronary artery disease patients with mild to moderate chronic kidney disease: Meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of bivalirudin in coronary artery disease patients with mild to moderate chronic kidney disease: Meta-analysis

Published:2018-05 Issue:5 Volume:71 Page:494-504
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Zeng Xiaofang,Lincoff A. Michael,Schulz-Schüpke Stefanie,Steg Philippe Gabriel,Elbez Yedid,Mehran Roxana,Stone Gregg W.,McAndrew Thomas,Lin Jianhui,Zhang Xindan,Shi Wenhai,Lei Han,Jing Zhicheng,Huang Wei

Funder

National Natural Science Foundation of China

Natural Science Foundation of Chongqing

Chongqing Municipal Health and Family Planning Commission

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease;Basra;J Am Coll Cardiol,2011

2. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease

3. Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: results from SYNERGY;Spinler;Int J Cardiol,2010

4. Safety of bivalirudin during percutaneous coronary interventions in patients with abnormal renal function;Roguin;Int J Cardiovasc Intervent,2005

5. Anticoagulation therapy in patients with chronic kidney disease;Saheb Sharif-Askari;Adv Exp Med Biol,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Cardiovascular Disease in Chronic Kidney Disease;Management of Chronic Kidney Disease;2023

2. Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study;Frontiers in Cardiovascular Medicine;2022-06-16

3. Efficacy and Safety of the Reduced Bivalirudin in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention Stratified by Renal Function (REDUCE BOLUS): A Single-Blind, Stratified Randomized, Non-inferiority Trial;Frontiers in Cardiovascular Medicine;2022-04-25

4. Antithrombotic therapies and their laboratory assessment;Rodak's Hematology;2020

5. Pros and cons of antithrombotic therapy in end-stage kidney disease: a 2019 update;Nephrology Dialysis Transplantation;2019-03-16